Eicosapentaenoic acid/arachidonic acid ratio and smoking status in elderly patients with type 2 diabetes mellitus

[1] Ziegler D(2005)Type 2 diabetes as an inflammatory cardiovascular disorder Curr Mol Med 5 309-322

[2] Matsuzaki M(2009)Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease Circ J 73 1283-1290

[3] Yokoyama M(2012)Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention Circ J 76 423-429

[4] Saito Y(2008)Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study J Am Coll Cardiol 52 417-424

[5] Origasa H(1984)Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease Am J Epidemiol 120 670-675

[6] Ishikawa Y(1998)Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study JAMA 279 119-124

[7] Oikawa S(2006)Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: the National Health and Nutrition Examination Survey Diabetes Care 29 531-537

[8] Sasaki J(2004)American Diabetes Association: Smoking and diabetes Diabetes Care 27 S74-S75

[9] Hishida H(2012)A review of smoking cessation interventions for smokers aged 50 and older Maturitas 71 131-141

[10] Itakura H(2005)Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Hypertension 45 142-161

[1] Ziegler D(2005)Type 2 diabetes as an inflammatory cardiovascular disorder Curr Mol Med 5 309-322

[2] Matsuzaki M(2009)Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease Circ J 73 1283-1290

[3] Yokoyama M(2012)Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention Circ J 76 423-429

[4] Saito Y(2008)Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study J Am Coll Cardiol 52 417-424

[5] Origasa H(1984)Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease Am J Epidemiol 120 670-675

[6] Ishikawa Y(1998)Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study JAMA 279 119-124

[7] Oikawa S(2006)Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999–2002: the National Health and Nutrition Examination Survey Diabetes Care 29 531-537

[8] Sasaki J(2004)American Diabetes Association: Smoking and diabetes Diabetes Care 27 S74-S75

[9] Hishida H(2012)A review of smoking cessation interventions for smokers aged 50 and older Maturitas 71 131-141

[10] Itakura H(2005)Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Hypertension 45 142-161